Correlation Between Theseus Pharmaceuticals and Beam Therapeutics

Can any of the company-specific risk be diversified away by investing in both Theseus Pharmaceuticals and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theseus Pharmaceuticals and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Theseus Pharmaceuticals and Beam Therapeutics, you can compare the effects of market volatilities on Theseus Pharmaceuticals and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theseus Pharmaceuticals with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theseus Pharmaceuticals and Beam Therapeutics.

Diversification Opportunities for Theseus Pharmaceuticals and Beam Therapeutics

-0.46

Correlation Coefficient

Theseus Pharmaceuticals  Beam Therapeutics

Very good diversification

The 3 months correlation between Theseus and Beam is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Theseus Pharmaceuticals and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and Theseus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theseus Pharmaceuticals are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of Theseus Pharmaceuticals i.e., Theseus Pharmaceuticals and Beam Therapeutics go up and down completely randomly.

Pair Corralation between Theseus Pharmaceuticals and Beam Therapeutics

If you would invest  2,412  in Beam Therapeutics on September 19, 2024 and sell it today you would earn a total of  454.00  from holding Beam Therapeutics or generate 18.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	4.55%
Values	Daily Returns

Theseus Pharmaceuticals  vs.  Beam Therapeutics

Theseus Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Theseus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Theseus Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Beam Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Beam Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Theseus Pharmaceuticals and Beam Therapeutics

The main advantage of trading using opposite Theseus Pharmaceuticals and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Theseus Pharmaceuticals position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.

The idea behind Theseus Pharmaceuticals and Beam Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.